Friday Schedule

DNA’s 39th Annual Convention Schedule

Friday, April 23, 2021

8:00 am – 9:00 am EST

General Session 301
Product Theater: TREMFYA: A First-line Biologic in Adult Patients with Moderate-to-Severe Plaque Psoriasis, Also Approved for Adults with Active Psoriatic Arthritis

Sponsored by Janssen Pharma (No CE)

Speaker: Sandri Johnson, MSN, FNP-BC

9:00 am – 9:15 am EST


9:15 am – 10:15 am EST

General Session 311
Topic/Title: Let’s Talk Skin: Atopic Dermatitis

A brief overview of the epidemiology, prevalence, presentation, and diagnosis of Atopic dermatitis. With a focus on both pharmacologic and non-pharmacologic options to assist with the treatment and management of the disease.

Speaker: Keischa Cash, DNP, APRN, FNP-BC

10:15 am – 10:30 am EST


10:30 am – 11:30 am EST

General Session 321
Topic/Title: Female Pattern Hair Loss: Navigating Cosmeceuticals and Nutraceuticals with our Patients

Female pattern hair loss (FPHL), also known as androgenic alopecia, is the most common form of hair loss seen in women. While there is rarely associated physical morbidity, the psychosocial impact has a significant on perceived well-being. Pharmacologic management options are limited for women, hair replacement and other medical procedures can be out of reach financially for many. The dermatology nurse and nurse practitioner be vital to help patients negotiate marketing claims and help guide decisions by having knowledge of the available evidence and helping patients evaluate online resources.

Speaker: Katrina Nice Masterson, DNP, RN, FNP-BC, DCNP

11:30 am – 11:45 am EST


11:45 am – 12:45 pm EST

General Session 331
Topic/Title: Psoriais in the 2020’s: Formerly Known as The Heartbreak of Psoriasis

This presentation will be an advanced and comprehensive discussion of all aspects of psoriasis, including a detailed introduction, epidemiology, pathophysiology, clinical presentation, prognosis, and management of the psoriatic patient. By the end of the presentation, the attendee should have a firm understanding of all aspects of the clinical manifestations of psoriasis and its management.

Speaker: Abel Jarell, MD, FAAD

12:45 pm – 1:00 pm EST


1:00 pm – 2:00 pm EST

General Session 341
Product Theater: What Sets Taltz Apart: An Overview of Long-Term Safety and Efficacy

Sponsored by Lilly USA (No CE)

Speaker: Lakshi Aldredge, MSN, ANP-BC, DCNP

2:00 pm – 2:15 pm EST


2:15 pm – 3:15 pm EST

General Session 351
Topic/Title: Top 5 Diagnoses Seen By Dermatology NPs

Top 5 Diagnoses Seen By Dermatology NPs description: This presentation will discuss the Top 5 most common diagnoses seen by Dermatology nurse practitioners. We will briefly cover diagnosis, etiology, treatment options, and pearls for patient care.

Speaker: Heather Onoday, FNP-C, DCNP

3:15 pm – 3:30 pm EST


3:30 pm – 4:30 pm EST

General Session 361
Topic/Title: Ethnic Dermatology

We are called to recognize disparities in access to quality healthcare provided to ethnic communities. While there are still a limited number of ethnically diverse clinicians currently practicing in dermatology in the US, there is an increasing body of literature which addresses Ethnic Dermatology. This presentation compiles a literature review of relevant historical, cultural and clinical information from experts in this discipline to enhance the knowledge base, and therefore the quality of care, in caring for patients with skin of color.

Speaker: Victoria Lazareth, MA, MSN, NP-C, DCNP

4:30 pm – 4:45 pm EST


4:45 pm – 5:45 pm EST

General Session 371
Topic/Title: Comedy Show

Laugh and Learn how humor reduces pain, improves mood, lowers stress hormones, boosts immunity, expedites creative problem solving and bonds us with our team. Recognize the symptoms of stress and when humor is most needed, and how to use humor appropriately in stressful situations and create an environment that invites humor that bonds team members.

Speaker: Nancy Norton, RN